Percutaneous venovenous perfusion-induced systemic hyperthermia for lung cancer: A phase I safety study

Annals of Thoracic Surgery

Volumn 77, Issue 6, 2004, Pages 1916-1925

  Zwischenberger, Joseph B ^a,b   Vertrees, Roger A ^a   Bedell, Eric A ^a   McQuitty, Christopher K ^a   Chernin, Jill M ^a   Woodson, Lee C ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

10

Indexed keywords

ARTICLE; BREATHING; CALCULATION; CENTRAL VEIN; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORE TEMPERATURE; ELECTROLYSIS; EXTRACORPOREAL CIRCULATION; FEEDBACK SYSTEM; GENERAL ANESTHESIA; HEPARINIZATION; HOMEOSTASIS; HUMAN; HYPERTHERMIA; LUNG CARCINOMA; LUNG METASTASIS; MOLECULAR EVOLUTION; PREOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; WEIGHT REDUCTION;

ADENOCARCINOMA; AGED; BODY TEMPERATURE; CARCINOMA, SQUAMOUS CELL; EXTRACORPOREAL CIRCULATION; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; LUNG NEOPLASMS; MALE; MIDDLE AGED; SURVIVAL RATE;

EID: 2542481610     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2003.10.111     Document Type: Article

References (38)

1. Jemal A., Thomas A., Murray T., Thun M. Cancer statistics, 2002. CA Cancer J Clin. 52:2002;23-47
2. Kelly K. Pharmacological treatments for lung cancer. Kane M.A., Bunn P.A. Biology of lung cancer. 1998;119-170 Marcel Dekker, New York
3. Harmon B.V., Corder A.M., Collins R.J., et al. Cell death induced in a murine mastocytoma by 42-47 degrees C heating in vitro evidence that the form of death changes from apoptosis to necrosis above a critical heat load. Int J Radiat Biol. 58:1990;845-858
4. Gabriele P., Orecchia R., Ragona R., Tseroni V., Sannazzari G.L. Hyperthermia alone in the treatment of recurrences of malignant tumors. Experience with 60 lesions. Cancer. 66:1990;2191-2195
5. Robins H.I., Hugander A., Cohen J.D. Whole body hyperthermia in the treatment of neoplastic disease. Radiol Clin North Am. 27:1989;603-610
6. Armour E.P., McEachern D., Wang Z., Corry P.M., Martinez A. Sensitivity of human cells to mild hyperthermia. Cancer Res. 53:1993;2740-2744
7. Vertrees R.A., Zwischenberger J.B., Boor P.J., Pencil S.D. Oncogenic ras results in increased cell kill due to defective thermoprotection in lung cancer cells. Ann Thorac Surg. 69:2000;1675-1680
8. Shen R.N., Hornback N.B., Shidnia H., Shupe R.E., Brahmi Z. Whole-body hyperthermia decreases lung metastases in lung tumor-bearing mice, possibly via a mechanism involving natural killer cells. J Clin Immunol. 7:1987;246-253
9. Brobeil A., Berman C., Cruse C.W., et al. Efficacy of hyperthermic isolated limb perfusion for extremity-confined recurrent melanoma. Ann Surg Oncol. 5:1998;376-383
10. Nagle V., Berry J., Bull J.M. Whole body hyperthermia with carboplatin (CBDCA) for treatment of advanced or metastatic GI adenocarcinomas. Proc Am Assoc Cancer Res. 40:1999;345
11. Vertrees R.A., Leeth A., Girouard M., Roach J.D., Zwischenberger J.B. Whole-body hyperthermia a review of theory, design and application. Perfusion. 17:2002;279-290
12. Gerweck L.E. Hyperthermia in cancer therapy the biological basis and unresolved questions. Cancer Res. 45:1985;3408-3414
13. Li G.C. Thermal biology and physiology in clinical hyperthermia current status and future needs. Cancer Res. 44:1984;4886s-4893s
14. Eisler K., Landauer B., Hipp R., et al. Experiences with therapeutic whole-body hyperthermia. Anaesthesist. 34:1985;299-303
15. Parks L.C., Minaberry D., Smith D.P., Neely W.A. Treatment of far-advanced bronchogenic carcinoma by extracorporeally induced systemic hyperthermia. J Thorac Cardiovasc Surg. 78:1979;883-892
16. Vertrees R.A., Deyo D.J., Tao W., Brunston R.L. Jr, Zwischenberger J.B. Parallel dialysis normalizes serum chemistries during venovenous perfusion induced hyperthermia. ASAIO J. 43:1997;M806-811
17. Vertrees R.A., Tao W., Pencil S.D., Sites J.P., Althoff D.P., Zwischenberger J.B. Induction of whole body hyperthemia with venovenous perfusion. ASAIO J. 42:1996;250-254
18. Vertrees R.A., Bidani A., Deyo D.J., Tao W., Zwischenberger J.B. Venovenous perfusion-induced systemic hyperthermia hemodynamics, blood flow, and thermal gradients. Ann Thorac Surg. 70:2000;644-652
19. Zwischenberger J.B., Vertrees R.A., Woodson L.C., et al. Percutaneous venovenous perfusion-induced systemic hyperthermia for advanced non-small cell lung cancer initial clinical experience. Ann Thorac Surg. 72:2001;234-242
20. Ash S.R., Blake D.E., Carr D.J., Carter C., Howard T., Makowka L. Clinical effects of a sorbent suspension dialysis system in treatment of hepatic coma (the BioLogic-DT). Int J Artif Organs. 15:1992;151-161
21. Baker J., Zwischenberger J.B., Breckenridge J., Stronck K., Bimbela A. Psychological assessment in perfusion-induced hyperthermia for lung cancer. Arch Clin Neuropsych. 14:1999;148. (abstract)
22. Sellins K.S., Cohen J.J. Hyperthermia induces apoptosis in thymocytes. Radiat Res. 126:1991;88-95
23. Skibba J.L., Powers R.H., Stadnicka A., Cullinane D.W., Almagro U.A., Kalbfleisch J.H. Oxidative stress as a precursor to the irreversible hepatocellular injury caused by hyperthermia. Int J Hyperthermia. 7:1991;749-761
24. Yatvin M.B., Abuirmeileh N.M., Vorpahl J.W., Elson C.E. Biological optimization of hyperthermia modification of tumor membrane lipids. Eur J Cancer Clin Oncol. 19:1983;657-663
25. Wong G.H., Kaspar R.L., Vehar G. Tumor necrosis factor and lymphotoxin protection against oxidative stress through induction of MnSOD. EXS. 77:1996;321-333
26. Vaupel P., Muller-Klieser W., Otte J., Manz R., Kallinowski F. Blood flow, tissue oxygenation, and pH-distribution in malignant tumors upon localized hyperthermia. Basic pathophysiological aspects and the role of various thermal doses. Strahlentherapie. 159:1983;73-81
27. Nahas G.G., Tannieres M.L., Lennon J.F. Direct measurement of leukocyte motility effects of pH and temperature. Proc Soc Exp Biol Med. 138:1971;350-352
28. Tonnesen A.S., Marnock C., Bull J.M., Morgenweck C.J., Fallon K.D. Sweating, hemodynamic responses, and thermal equilibration during hyperthermia in humans. J Appl Physiol. 62:1987;1596-1602
29. Koga S., Maeta M. Extracorporeally induced total-body hyperthermia for disseminated cancer. Adv Exp Med Biol. 267:1990;177-188
30. Bull J.M., Lees D.E., Schuette W.H., Smith R., Glatstein E., DeVita V.T. Jr. Immunological and physiological responses to whole-body hyperthermia. Natl Cancer Inst Monogr. 61:1982;177-181
31. Roizin-Towle L., Pirro J.P. The response of human and rodent cells to hyperthermia. Int J Radiat Oncol Biol Phys. 20:1991;751-756
32. Zwierzina W.D., Herold M., Gunther R., Kunz F. [Blood coagulation in hyperthermia]. Z Rheumatol. 39:1980;368-378
33. Strother S.V., Bull J.M., Branham S.A. Activation of coagulation during therapeutic whole body hyperthermia. Thromb Res. 43:1986;353-360
34. Steinhart C.R., Ash S.R., Gingrich C., Sapir D., Keeling G.N., Yatvin M.B. Effect of whole-body hyperthermia on AIDS patients with Kaposi's sarcoma a pilot study. J Acquir Immune Defic Syndr Hum Retrovirol. 11:1996;271-281
35. Herman T.S., Stickney D.G., Gernew E.W. Differential rates of heating influence hyperthermia induced cytotoxicity in normal and transformed cells in vitro. Proc Am Assoc Cancer Res. 20:1979;165. (abstract)
36. Danson S., Middleton M.R., O'Byrne K.J., et al. Phase III trial of gemcitabine, and carboplatin versus mitomycin, ifosfamide, and cisplatin or mitomycin, vinblastine, and cisplatin in patients with advanced nonsmall cell lung carcinoma. Cancer. 98:2003;542-553
37. Larkin J.M., Edwards W.S., Smith D.E., Clark P.J. Systemic thermotherapy description of a method and physiologic tolerance in clinical subjects. Cancer. 40:1977;3155-3159
38. Bull J.M., Lees D., Schuette W., et al. Whole body hyperthermia a phase-I trial of a potential adjuvant to chemotherapy. Ann Intern Med. 90:1979;317-323